The National Health and Medical Research Council (NHMRC) of Australia has approved the world’s first clinical guideline regarding the use of MDMA-assisted psychotherapy in the treatment of PTSD.
The synthetic substance MDMA is widely known to the general public as “Ecstasy.” This substance possesses both stimulant and hallucinogenic properties. In a clinical context, its use involves psychotherapeutic sessions where the drug helps the patient overcome emotional barriers and safely “revisit” traumatic memories.
MDMA induces a massive release of serotonin, dopamine, and norepinephrine in the body, which increases feelings of trust, empathy, and emotional closeness. For individuals suffering from PTSD, these factors significantly improve the effectiveness of the therapeutic process.
Developed by Monash University, this document is based on the “gold standard” of GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) and aims to support medical professionals and patients in the decision-making process.
Australia is the first country to reclassify MDMA from a list of prohibited substances to controlled medicines.
According to the guideline, this therapy is not considered a routine treatment and should be limited only to adult patients who have exhibited severe symptoms for at least six months and for whom first-line traditional methods have proven ineffective.
The document strictly prohibits the use of MDMA therapy in high-risk groups, including pregnant women and individuals with cardiovascular or psychotic disorders. This regulation is critically important, as nearly half of those suffering from PTSD do not respond to existing treatments.
Despite its potential benefits, the use of MDMA requires strict medical supervision due to its physiological effects. The substance causes an increased heart rate and elevated blood pressure, posing a risk to individuals with cardiovascular diseases.
For this reason, Australia’s new guideline emphasizes that the drug should only be used in a controlled environment by authorized psychiatrists to minimize the likelihood of both physical complications and psychotic reactions.
